SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

XORTX Therapeutics Inc. (XRTX) News

Track canonical SquawkNews coverage tagged to XRTX, XORTX Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol XRTX Asset equity Sector Markets 90 days 7 Last 1.71 Updated Sep 18, 2026, 12:11 PM UTC Open live news feed
L XRTX - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity XRTX - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity REGULATION | Sep 18, 2026, 12:11 PM UTC L XORTX Therapeutics starts drug and tablet manufacturing for XRx-026 XORTX Therapeutics Inc said it has initiated drug and tablet manufacturing for its XRx-026 program. EQUITY | Sep 10, 2026, 08:13 PM UTC L XORTX initiates clinical and commercial manufacturing of XORLO™ ● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ●CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) -- XORTX Thera EQUITY | Sep 10, 2026, 08:11 PM UTC L XORTX Announces Termination and Postponement of Investor Relations Program XORTX Announces Termination and Postponement of Investor Relations Program EQUITY | Aug 28, 2026, 11:07 AM UTC L XRTX terminates and postpones investor relations program XRTX/XORTX said it is terminating and postponing its investor relations program. EQUITY | Aug 28, 2026, 11:00 AM UTC L XORTX Director Resigns XORTX director resigns EQUITY | Jul 31, 2026, 09:00 PM UTC L XRTX - XORTX Appoints New Director XRTX - XORTX Appoints New Director EQUITY | Jul 29, 2026, 11:01 AM UTC L 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by EQUITY | Jun 30, 2026, 12:05 PM UTC